US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 6, 2013 (14 years ago)

Ciprofloxacin Tablets USP

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxacin tablet.

What was recalled

Ciprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp., Eatowntown, NJ 07724 by Hikma Pharmaceuticals, Amman, Jordan, NDC 0143-9928-01

Recalling firm
West-ward Pharmaceutical Corp.
NDC code
0143-9928-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-220-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ciprofloxacin recalls

See all
Class II · Moderate risk Ongoing

Ciprofloxacin Ophthalmic Solution USP

Reason Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

FDC Limited NDC 69315-308-05 D-0282-2025
Class II · Moderate risk Ongoing

Ciprofloxacin Ophth Solution

Reason Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

Direct Rx NDC 61919-795-05 D-0364-2025
Class II · Moderate risk Ongoing

Ciprofloxacin Ophthalmic Solution USP

Reason Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

FDC Limited NDC 69315-308-05 D-0182-2025
Class II · Moderate risk Ongoing

Ciprofloxacin ophthalmic solution USP

Reason Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

FDC Limited NDC 69315-308-10 D-0623-2024